Internal Medicine · Valencia, CA
NPI
1558474262
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
26357 McBean Pkwy
Valencia, CA, 91355
Phone (661) 222-2658
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$274K
4,997 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Clement C Kim prescribed most often to Medicare patients was Atorvastatin Calcium, with 398 prescriptions and refills. In total Clement C Kim wrote 4,997 Medicare prescriptions that cost $274K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-12-15.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Atorvastatin Calcium Generic | 398 | 1,230 | 138 | $5,424 |
| Losartan Potassium Generic | 276 | 876 | 93 | $3,559 |
| Amlodipine Besylate Generic | 240 | 739 | 77 | $2,960 |
| Lisinopril Generic | 156 | 476 | 50 | $2,156 |
| Levothyroxine Sodium Generic | 152 | 462 | 50 | $2,763 |
| Gabapentin Generic | 151 | 397 | 46 | $3,526 |
| Tamsulosin Hcl Generic | 137 | 387 | 47 | $2,411 |
| Metformin Hcl Er Metformin Hcl | 111 | 359 | 41 | $1,134 |
| Furosemide Generic | 94 | 229 | 29 | $1,302 |
| Metoprolol Succinate Generic | 83 | 251 | 31 | $1,042 |
| Pantoprazole Sodium Generic | 82 | 207 | 30 | $1,078 |
| Atenolol Generic | 81 | 263 | 29 | $994 |
| Finasteride Generic | 78 | 231 | 25 | $1,323 |
| Omeprazole Generic | 77 | 195 | 28 | $822 |
| Hydrochlorothiazide Generic | 76 | 239 | 25 | $826 |
Brand drugs: 371 claims; generic drugs: 4,591 claims; opioid claims: 202.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Clement C Kim were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.